US$ 25.30
aod9604 peptide purpose AOD 9604 5MG AOD-9604 (10mg vials) - Peptide
Description
Unlike semaglutide, tirzepatide targets both GLP-1 and GIP (gastric inhibitory polypeptide) receptors, enhancing fat metabolism and insulin sensitivity

Modern Drug Discovery

J Med Chem 2017
IJMS 21, 7698

The stomach has fewer blood vessels and nerve endings, making it the perfect location for injection less painful, easy to reach, and less likely to poke a blood vessel

Mechanisms of obesity-associated cardiovascular and renal disease
